1118567-05-7 Bexagliflozin

Pwopriyete

Aparans cristalline solid
Pwen bouyi: 671. 0 ± 55. 0 degre
Dansite 1.41
Depo tanperati. Magazen nan -20 degre
solubility dmso: 1 0 0.0 (max conc. mg/ml); 215.08 (max conc. mm)
PKA13.23 ± 0. 70

 

Aplikasyon:

Bexagliflozin se yon inibitè SGLT2, ki se sitou itilize amelyore kontwòl sik nan san nan granmoun ki kalite 2 pasyan dyabèt. Li ka diminye sik nan san, pwa ak san presyon pa anpeche SGLT2 nan selil ren epitelyal ren, ogmante konsomasyon chalè kò, diminye retansyon likid, ak ogmante eskresyon glikoz pipi. Bexagliflozin gen yon efè pwoteksyon klè sou sante kadyovaskilè ak ren, e li te fè byen nan esè klinik ak efikasite siyifikatif ak sekirite segondè
 

Sinonim:

Bexagliflozin

1118567-05-7

Egt1442

Brenzavvy

EGT -1442

Thr -1442

bexagliflozina

Thr1442

beksèlflozinum

(2s, 3r, 4r, 5s, 6r) -2- (4- chloro -3- (4- (2- cyclopropoxyethoxy) Benz yl) fenil) -6- (hydroxymethyl) tetrahydro -2 h-piran -3, 4, 5- triol

(2s, 3r, 4r, 5s, 6r) -2- [4- chloro -3- [4- (2- cyclopropyloxyetho xy) fenil] methyl] fenil] -6- (hydroxymethyl) oxane -3, 4, 5- triol

D-glucitol, 1, 5- anhydro -1- C-(4- chloro -3- ((4- (2- (cyclopropyloxy) ethoxy-)-) -m).

(1s) -1, 5- anhydro -1- C-[4- chloro -3- [4- [2- (cyclopropyloxy) ethoxyy-

(2s, 3r, 4r, 5s, 6r) -2- (4- chloro -3- ((4- ({{9} l) methyl) fenil) -6- (hydroxymethyl) tetrahydro -2 h-piran -3, 4, 5- triolol

Bexacat

Brenzavy

(2s, 3r, 4r, 5s, 6r) -2- [4- chloro -3- ({4- [{{9} l} methyl) fenil] -6- (hydroxymethyl) tetrahydro -2 h-piran -3, 4, 5- triol

D-glucitol, 1, 5- anhydro -1- c-[4- chloro -3- [[4- [2- (cyclopropyloxy) ethoxy-]-

tablèt bexagliflozin

EGT1442; Bexagliflozin

Bexagliflozin

 

Baj popilè: 1118567-05-7 Bexagliflozin, Lachin 1118567-05-7 BEXAGLIFLOZIN